Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Oncology Drugs 79
Optical Disorders Drugs 78
Optical 75
Immune Disorders Drugs 67
Cardiovascular Drugs 46
Biopharmaceuticals 40
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Genomics 30
Biotechnology 28
Clinical Trials 28
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Therapeutic Area 5
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Diabetes Devices 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Cardiology 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

676 Results (Page 2 of 34)
- Relevance
  Sort by

Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type, Route of Administration, Indication - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Gout Therapeutics - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5491EUR$5,600USD£4,576GBP

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024

 Report
September 2024
700 Pages
Global

From

€3917EUR$3,995USD£3,264GBP

Aflibercept (Eylea) Biosimilars Pipeline Review

 Report
November 2024
Global

From

€300EUR$328USD£259GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

 Report
September 2024
750 Pages
Global

From

€3917EUR$3,995USD£3,264GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Anterior Uveitis Treatment Market by Treatment Type, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
325 Pages
Global

From

€4706EUR$4,799USD£3,921GBP

Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024

 Report
September 2024
550 Pages
Global

From

€3917EUR$3,995USD£3,264GBP

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 Report
April 2020
536 Pages
Global

From

€4804EUR$4,899USD£4,003GBP

Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
January 2022
242 Pages
Global

From

€4706EUR$4,799USD£3,921GBP

Gout Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Corticosteroids, Colchicine), By Disease Condition (Acute, Chronic), By Distribution Channel, By Region, And Segment Forecasts, 2023-2030

 Report
June 2023
100 Pages
Global

From

€5835EUR$5,950USD£4,862GBP

Companion Diagnostics Development Services Market: Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
March 2022
405 Pages
Global

From

€4706EUR$4,799USD£3,921GBP

Microneedle Flu Vaccine Market

 Report
January 2024
200 Pages
Global

From

€4069EUR$4,150USD£3,391GBP

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Gout Therapeutics Market by Drug Class, Treatment, Route of Administration, Application - Global Forecast 2025-2030

 Report
October 2024
196 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
182 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Natural Killer Cell Therapeutics Market by Therapeutics, Approaches, Application, End User - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Skin Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4658EUR$4,750USD£3,881GBP

Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

 Report
October 2023
161 Pages
Global

From

€2451EUR$2,500USD£2,043GBP

Antibody Drugs: Technologies and Global Markets

 Report
September 2024
156 Pages
Global

From

€4560EUR$4,650USD£3,799GBP

676 Results (Page 2 of 34)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.